Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hickory, NC
NPI
1134198740
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
311 9th Avenue Dr NE
Hickory, NC, 28601
Phone (828) 322-7338
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
3,693 services
Medicare patients, 2024
381
Average age 73
Drug cost, 2024
$2.2M
5,979 prescriptions
Company payments, 2025
$1,989
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Venkatarama S Donepudi was code 84443 (clinical chemistry), 390 times for 264 patients. In total Venkatarama S Donepudi billed 3,693 services in 39 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 84443 Clinical Chemistry | Office | 390 | 264 | $16.23 | $6,330 |
| 84439 Clinical Chemistry | Office | 389 | 264 | $8.74 | $3,400 |
| 84481 Clinical Chemistry | Office | 310 | 235 | $16.36 | $5,073 |
| 99214 Office E&M - Established | Office | 306 | 215 | $80.32 | $25K |
| 83036 Blood Count | Office | 249 | 124 | $9.41 | $2,342 |
| 36415 Venipuncture Blood Collection | Office | 187 | 144 | $8.61 | $1,609 |
| 99213 Office E&M - Established | Office | 175 | 154 | $60.19 | $11K |
| 99215 Office E&M - Established | Office | 144 | 97 | $112.67 | $16K |
| 82306 Clinical Chemistry | Office | 116 | 96 | $29.01 | $3,365 |
| 95251 Test - Miscellaneous | Office | 101 | 59 | $23.96 | $2,420 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 85 | 82 | $12.08 | $1,027 |
| 81003 Clinical Chemistry | Office | 84 | 74 | $2.20 | $185 |
| 82570 Clinical Chemistry | Office | 77 | 70 | $5.08 | $391 |
| 82043 Clinical Chemistry | Office | 77 | 70 | $5.66 | $436 |
| 82533 Clinical Chemistry | Office | 41 | 34 | $15.58 | $639 |
By year: 2022 $129K for 5,447 services; 2023 $111K for 4,751 services; 2024 $97K for 3,693 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84443 Clinical Chemistry | 390 | 264 | $16.23 | $6,330 |
| 84439 Clinical Chemistry | 389 | 264 | $8.74 | $3,400 |
| 84481 Clinical Chemistry | 310 | 235 | $16.36 | $5,073 |
| 83036 Blood Count | 249 | 124 | $9.41 | $2,342 |
| 36415 Venipuncture Blood Collection | 187 | 144 | $8.61 | $1,609 |
| 82306 Clinical Chemistry | 116 | 96 | $29.01 | $3,365 |
| 81003 Clinical Chemistry | 84 | 74 | $2.20 | $185 |
| 82570 Clinical Chemistry | 77 | 70 | $5.08 | $391 |
| 82043 Clinical Chemistry | 77 | 70 | $5.66 | $436 |
| 82533 Clinical Chemistry | 41 | 34 | $15.58 | $639 |
Medicare prescription drug claims, 2024
In 2024, the drug Venkatarama S Donepudi prescribed most often to Medicare patients was Levothyroxine Sodium, with 867 prescriptions and refills. In total Venkatarama S Donepudi wrote 5,979 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 867 | 1,958 | 207 | $7,481 |
| Synthroid Levothyroxine Sodium | 559 | 1,019 | 103 | $47K |
| Ozempic Semaglutide | 320 | 428 | 59 | $410K |
| Unithroid Levothyroxine Sodium | 292 | 584 | 71 | $22K |
| Methimazole Generic | 238 | 448 | 56 | $1,791 |
| Metformin Hcl Er Metformin Hcl | 216 | 514 | 59 | $1,474 |
| Jardiance Empagliflozin | 157 | 250 | 30 | $148K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 136 | 227 | 33 | $74K |
| Rosuvastatin Calcium Generic | 134 | 313 | 36 | $1,218 |
| Tresiba Flextouch U-200 Insulin Degludec | 110 | 193 | 27 | $103K |
| Liothyronine Sodium Generic | 109 | 206 | 23 | $4,490 |
| Pioglitazone Hcl Generic | 103 | 238 | 25 | $1,510 |
| Metformin Hcl Generic | 100 | 233 | 30 | $837 |
| Tresiba Flextouch U-100 Insulin Degludec | 99 | 164 | 27 | $49K |
| Hydrocortisone Generic | 94 | 165 | 18 | $4,098 |
Brand drugs: 3,272 claims; generic drugs: 2,457 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Venkatarama S Donepudi $1,989 ($1,989 in general payments such as food, travel and fees) from 32 companies. The largest payer was Corcept Therapeutics with $162.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 9 | $162 |
| Ascendis Pharma Endocrinology Inc ASND | 7 | $160 |
| Novo Nordisk Inc NVO | 7 | $121 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $111 |
| Lilly USA, LLC LLY | 6 | $107 |
| Radius Health, Inc. | 4 | $99.87 |
| Amgen Inc. AMGN | 6 | $97.97 |
| Recordati_rare_diseases_inc. | 4 | $79.42 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $78.23 |
| IBSA Pharma Inc. | 3 | $77.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.